| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Cardiotrophin-1 (Digna Biotech/Biotecnol) | CT-1 | Phase 2 Clinical | Biotecnol Sa, Digna Biotech Sl, Genentech Inc | Liver Failure; Acute Kidney Injury; Myocardial Reperfusion Injury; Ischemia | Details |




